AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glipwin GM 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Clipwin Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glipwin GM 1mg/500mg Tablet SR

DiaBeta Duo 1mg/500mg Extended-Release Tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. These tablets help regulate blood glucose. Consume DiaBeta Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is vital; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are crucial for prevention. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glipwin GM 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glipwin GM 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glipwin GM 1mg/500mg Sustained-Release tablets should be taken with meals.

Common Side effects of Glipwin GM 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glipwin GM 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glipwin GM 1mg/500mg sustained-release tablet should be taken with a meal.

How Glipwin GM 1mg/500mg Tablet SR works:

Glipwin GM SR tablets (1mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glipwin GM 1mg/500mg SR tablet use is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glipwin GM 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Extended-release Glipwin GM tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glipwin GM 1mg/500mg SR tablets, as dosage modification may be necessary. Medical advice is recommended. Glipwin GM 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glipwin GM 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In those with mild to moderate liver disease, initiate treatment with a low Glipwin GM 1mg/500mg SR tablet dose; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Glipwin GM 1mg/500mg Tablet SR :

Should you forget to take a Glipwin GM 1mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glipwin GM 1mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Type of Treatment Diabetes Management

FAQs on Glipwin GM 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glipwin GM 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Glipwin GM and seek immediate medical attention.
Glipwin GM 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glipwin GM 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glipwin GM 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glipwin GM 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glipwin GM 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, risking hypoglycemia, and increase the likelihood of lactic acidosis.
Glipwin GM 1mg/500mg Tabl...
53
MRP 61
13% off